+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Calcitonin"

From
Osteoporosis Treatment Global Market Report 2024 - Product Thumbnail Image

Osteoporosis Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Parathyroid Hormone Global Market Report 2024 - Product Thumbnail Image

Parathyroid Hormone Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
Osteoporosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Osteoporosis Therapeutics - Global Strategic Business Report

  • Report
  • April 2024
  • 340 Pages
  • Global
From
From
From
From
From
Osteoporosis Market and Forecast Analysis - Product Thumbnail Image

Osteoporosis Market and Forecast Analysis

  • Report
  • January 2019
  • 212 Pages
  • Global
From
From
Loading Indicator

Calcitonin is a hormone produced by the thyroid gland and is used to treat endocrine and metabolic disorders. It is used to treat hypercalcemia, a condition in which the body has too much calcium in the blood, and to treat osteoporosis, a condition in which bones become weak and brittle. Calcitonin is also used to treat Paget's disease, a disorder of the bones. It is available in both injectable and oral forms. Calcitonin is a relatively small market compared to other endocrine and metabolic disorder drugs. It is used mainly to treat hypercalcemia and osteoporosis, and is not used as widely as other drugs for these conditions. Some companies in the calcitonin market include Amgen, Eli Lilly, Novartis, and Pfizer. Show Less Read more